By Investing.com Staff Shares of Catalent (NYSE:CTLT) surged 24% in pre-open trading Monday following a report over the weekend from Bloomberg News that Danaher (NYSE:DHR) has...
Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT). According to the sources, the recent moves by...
By Daniel Shvartsman Investing.com -- Entering the last trading day of the year, it's no surprise to find the 2022 scoreboard filled with energy winners and tech losers. The Dow...
Last week’s stock market rally had a few anomalies that investors should cast a wary eye on. The main oddity saw investors pull billions of dollars out of two of the biggest...
Last August, a little section of U.S. President Joe Biden’s much-touted Inflation Reduction Act caught the attention of investors. It introduced a 1% tax on stock...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.
| Average | 69.33 (+2.14% Upside) |
| High | 100.00 |
| Low | 44.00 |
| Price | 67.88 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Strong Buy | Neutral |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Buy | Strong Sell |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 264.10 | 264.10 | 264.10 | -2.80 | -1.05% | 41.46K | Lagos | |||
| 0.50 | 0.50 | 0.50 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 63.00 | 63.00 | 63.00 | 0.00 | 0.00% | 75.22K | Lagos | |||
| 0.98 | 0.98 | 0.98 | 0.00 | 0.00% | 321.60K | Lagos | |||
| 1,085.00 | 1,085.00 | 1,085.00 | +5.00 | +0.46% | 31.78K | Lagos | |||
| 25.10 | 25.20 | 25.10 | -0.10 | -0.40% | 50.59M | Lagos | |||
| 40.50 | 40.50 | 40.50 | -1.30 | -3.11% | 360.96K | Lagos | |||
| 2.29 | 2.31 | 2.26 | +0.060 | +2.69% | 1.69M | Lagos | |||
| 5.89 | 5.92 | 5.90 | -0.080 | -1.33% | 3.56M | Lagos | |||
| 11.95 | 11.95 | 11.90 | 0.00 | 0.00% | 1.58M | Lagos | |||
| 29.50 | 29.50 | 29.50 | -0.45 | -1.50% | 335.94K | Lagos | |||
| 22.25 | 22.30 | 22.25 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 16.55 | 16.55 | 16.55 | -1.10 | -6.23% | 27.59K | Lagos | |||
| 210.00 | 210.00 | 210.00 | -14.00 | -6.25% | 124.02K | Lagos | |||
| 8.40 | 8.45 | 8.30 | -0.05 | -0.59% | 14.94M | Lagos |